Tessella. Complex problems. Solved.

Archive for February, 2012

Free webinar – Optimising Drug Development: Enabling Quantitative Decision Making Through Simulation

Wednesday, February 29th, 2012

Watch on youtube In this webinar Tom Parke discusses key questions about the use of quantitative decision making in drug development through simulation including: How can simulations of drug response be used to design a trial? With so many issues, including sub-population analysis, comparative effectiveness and testing drugs in combination, how can you decide what [...]

Aptiv Solutions, the first CRO to license Tessella and Berry Consultants FACTS technology

Tuesday, February 28th, 2012

Aptiv Solutions, a global biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today a collaboration with Tessella, a world leader in the provision of science powered technology and consulting services and Berry Consultants, leaders in the Bayesian approach to medical statistics, to deliver integrated early [...]

Tessella awarded 2 stars from Sunday Times Best Places to Work 2012

Monday, February 6th, 2012

Tessella has the pleasure to announce that it has been accredited with 2 stars out of 3 for the Sunday Times Best Places to work.

Webinar: Optimising Drug Development: Enabling quantitative decision making in drug development through simulation

Friday, February 3rd, 2012

Register for the Live Webinar 21 Feb 3pm GMT In this free webinar Tom Parke discusses key questions about the use of quantitative decision making in drug development through simulation. Model based drug development produces estimates of the likely response to a drug, how should this be used to design a trial? The environment for [...]